Vergelijking

Histrelin vs. Lanreotid

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

220810-26-4

108736-35-2

Molecuulmassa

1323.52 g/mol

1096.34 g/mol

Halfwaardetijd

geen gegevens

Sequentie

geen gegevens

Werkingsmechanisme

Histrelin

Continuous GnRH-agonist stimulation downregulates and desensitises the pituitary GnRH receptors — after the initial rise, LH, FSH and the sex hormones fall persistently.

Lanreotid

Lanreotide activates somatostatin receptors (chiefly SSTR2, additionally SSTR5), thereby suppressing the release of growth hormone, IGF-1 and various gastrointestinal and neuroendocrine hormones. It is metabolically far more stable than natural somatostatin.

Bewijsbasis

Hoogste bewijs

Humane RCT

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Histrelin	Lanreotid
Duitsland	Op recept	Op recept
Verenigde Staten	Op recept	Op recept

Volledige vermeldingen

Histrelin

Volledige vermelding →

Lanreotid

Volledige vermelding →

Frequently asked questions

What is the difference between Histrelin and Lanreotid?: Histrelin is classified as "Onderzoek (overig)", while Lanreotid is classified as "Onderzoek (overig)". Histrelin: Histrelin is a nonapeptide GnRH agonist delivered as a once-yearly implant. Approved for central precocious puberty in children (Supprelin LA) and advanced prostate cancer (Vantas). Lanreotid: Lanreotide is a synthetic cyclic octapeptide analog of somatostatin. It binds preferentially to the somatostatin receptors SSTR2 and SSTR5 and is approved for treating acromegaly and certain neuroendocrine tumours. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Histrelin or Lanreotid?: The highest available evidence level is "Humane RCT" for Histrelin and "Humane RCT" for Lanreotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Histrelin and Lanreotid in Germany and the United States?: Duitsland: Histrelin — Op recept, Lanreotid — Op recept. Verenigde Staten: Histrelin — Op recept, Lanreotid — Op recept. These are factual summaries with source and review date on the individual pages.

Country

Histrelin

Lanreotid

Duitsland

Op recept

Verenigde Staten

Op recept

Frequently asked questions

What is the difference between Histrelin and Lanreotid?

Histrelin is classified as "Onderzoek (overig)", while Lanreotid is classified as "Onderzoek (overig)". Histrelin: Histrelin is a nonapeptide GnRH agonist delivered as a once-yearly implant. Approved for central precocious puberty in children (Supprelin LA) and advanced prostate cancer (Vantas). Lanreotid: Lanreotide is a synthetic cyclic octapeptide analog of somatostatin. It binds preferentially to the somatostatin receptors SSTR2 and SSTR5 and is approved for treating acromegaly and certain neuroendocrine tumours. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Histrelin or Lanreotid?

The highest available evidence level is "Humane RCT" for Histrelin and "Humane RCT" for Lanreotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Histrelin and Lanreotid in Germany and the United States?

Duitsland: Histrelin — Op recept, Lanreotid — Op recept. Verenigde Staten: Histrelin — Op recept, Lanreotid — Op recept. These are factual summaries with source and review date on the individual pages.